A
Atea Pharmaceuticals, Inc.
AVIR · NASDAQ · Healthcare · 410M
Price · close
$5.43
+1.31% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.6×
Enterprise value / EBITDAEV/EBITDA
-2.1×
Free cash flow yieldFCF yield
-29.8%
Return on equityROE
-57.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.